MEFLIAM PLUS 100MG/220MG TABLET 6
Artesunate is an antimalarial drug administered for the treatment of severe chloroquine resistant malaria and complicated malaria like cerebral malaria.
Mefloquine is an antimalarial medication. It is used in the treatment of malaria (serious condition that can cause death) and also to prevent malaria in people who are visiting areas such as Africa, South America, and Southern Asia, where malaria is common. The drug functions by inhibiting the growth of parasites in the red blood cells of the human body. It can also be used for other purposes, but consult your doctor.
The most common side effects of this drug are abnormal blood cell count, abnormal liver function tests, anaemia, bradycardia, dizziness, gastrointestinal disturbance, altered heart rate, or feeling of discomfort.
The common side effects of this drug are abdominal pain, abnormal dreams, anxiety, chills, depression, diarrhoea, dizziness, fever, headache, altered heart rate, insomnia, itching, loss of appetite, muscle pain, nausea, rash, ringing in ear, vertigo, visual impairment, vomiting, fatigue, (blistering, loosening, peeling, or redness of the skin), chest pain or discomfort, confusion, convulsions (seizures), cough or hoarseness, fainting, sleepiness and increased sweating.
Artesunate administration is usually safe and well-tolerated by patients. In severe malaria treatment artesunate delayed haemolysis (occurring around two weeks post treatment) is observed. Though, it is not clear whether haemolysis is induced by artesunate or malaria itself.
Mefloquine should be carefully administered to patients having a history of depression. When taken as a preventive drug, if psychiatric symptoms such as acute anxiety, depression, restlessness or confusion are observed, it implies that there are serious psychiatric disturbances or neurologic adverse reactions that need immediate attention. Make sure to inform the doctor about such instances.